Cambridge, UK, 21st March 2012 – TTP Labtech will showcase its renowned acumen? eX3 for screening multiplexed cell-based imaging assays, as well as mirrorball? for high sensitivity screening during antibody development at the American Association for Cancer Research (AACR) in Chicago 1 – 4 April. Visit booth 142 to see the wide range of high-content screening applications that acumen eX3 is used for in cancer research.
Enabling high throughput for high-content screening (HCS), the acumen eX3 laser scanning imaging cytometer is the fastest high-content imager currently on the market. With the ability to analyse over 300,000 wells a day at a resolution equivalent to a 20x microscope objective, acumen eX3 can perform multiplex assays in cells, tissues, or small animals. This enables you to assess multiple parameters (for example, mitotic index, colony formation, cell adhesion, angiogenesis) in a single assay, which is essential when studying complex disease states and pathogens.
acumen eX3 is flexible and simple to use - its speed and multiplexing capabilities allow you to significantly reduce the time to results in the discovery of novel cellular pathways and new therapeutic strategies. Recent studies have demonstrated the effectiveness of the acumen eX3 in the identification of the roles of protein kinase C a & d isoforms in PMA-induced HB-EGF ectoderm shedding, the high content screening analysis of neutrophil chemotaxis assays and the inhibition of mitotic progression and induction of vascular normalisation.
TTP Labtech is also displaying mirrorball, a high sensitivity laser scanning microplate cytometer for antibody discovery, which provides a simple and easy solution to automated hybridoma screening.
For more information please visit booth 142 during AACR or www.ttplabtech.com. For real time news and updates, follow us on twitter @ttplabtech.
About TTP Labtech Limited
Based near Cambridge, UK, TTP Labtech creates, designs and manufactures robust, reliable and easy-to-use instrumentation to offer life scientists better tools and techniques, simplifying complex operations, saving time and material costs. We provide state-of-the-art solutions developed for specific product areas including: cell-based screening (acumen?, mirrorball?); sample management (comPOUND?), low liquid handling (mosquito?) and the management of analytical automation (lab2lab).
TTP Labtech is owned by its employees, and our continued drive to innovate combines cutting edge science with first rate engineering, manufacturing and outstanding customer support.
www.ttplabtech.com
